Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic
Top Cited Papers
- 27 March 2021
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 104 (1) , 43-48
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Telehealth Interventions to Improve Obstetric and Gynecologic Health OutcomesObstetrics & Gynecology, 2020
- TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United StatesContraception, 2019
- Women's Experiences Using Telemedicine to Attend Abortion Information Visits in Utah: A Qualitative StudyWomen's Health Issues, 2019
- Medication Abortion Provided Through Telemedicine in Four U.S. StatesObstetrics & Gynecology, 2019
- Foregoing Rh testing and anti-D immunoglobulin for women presenting for early abortion: a recommendation from the National Abortion Federation's Clinical Policies CommitteeContraception, 2019
- Telemedicine for medical abortion: a systematic reviewBJOG: An International Journal of Obstetrics & Gynaecology, 2019
- Safety and acceptability of medical abortion through telemedicine after 9 weeks of gestation: a population‐based cohort studyBJOG: An International Journal of Obstetrics & Gynaecology, 2018
- Simplified medical abortion screening: a demonstration projectContraception, 2018
- Mifepristone With Buccal Misoprostol for Medical AbortionObstetrics & Gynecology, 2015
- Changes in Service Delivery Patterns After Introduction of Telemedicine Provision of Medical Abortion in IowaAmerican Journal of Public Health, 2013